Vasopressin: Its current role in anesthetic practice

Indian Journal of Critical Care Medicine

Volumn 15, Issue 2, 2011, Pages 71-77

  Mitra, Jayanta K ^a   Roy, Jayeeta ^a   Sengupta, Saikat ^b  

^a WBUHS   (India)

^b Apollo Gleneagles Hospital   (India)

Author keywords

Cardiopulmonary resuscitation; hemorrhagic shock; operating room; septic shock; vasopressin

Indexed keywords

ADRENALIN; ARGIPRESSIN; BLOOD CLOTTING FACTOR 7; CORTICOTROPIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; LYPRESSIN; NEUROTRANSMITTER; NORADRENALIN; ORNIPRESSIN; TERLIPRESSIN; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V3 RECEPTOR; VON WILLEBRAND FACTOR;

ANAPHYLACTIC SHOCK; BILIRUBIN BLOOD LEVEL; BINDING AFFINITY; BLEEDING DISORDER; BRAIN INJURY; BRONCHOSPASM; CARDIOGENIC SHOCK; CLINICAL PRACTICE; CONTINUOUS INFUSION; CORONARY ARTERY BLOOD FLOW; DIABETES INSIPIDUS; DRUG COST; DRUG ELIMINATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; ENZYME ACTIVITY; EPIDURAL ANESTHESIA; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART FAILURE; HEART OUTPUT; HEART PERFORMANCE; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HEMORRHAGIC SHOCK; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTENSION; INTESTINE ISCHEMIA; KIDNEY DISEASE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY (TOPIC); NEUROHYPOPHYSIS; PHEOCHROMOCYTOMA; PLASMA OSMOLALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTORY HYPOTENSION; RESUSCITATION; RETROSPECTIVE STUDY; REVIEW; SEPTIC SHOCK; SHOCK; SIDE EFFECT; SKIN NECROSIS; SPINAL ANESTHESIA; SUBARACHNOID HEMORRHAGE; THROMBOCYTE COUNT; TISSUE OXYGENATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URINE OSMOLALITY; VASCULAR RESISTANCE; VASODILATORY SHOCK; WATER RETENTION;

EID: 79960832298     PISSN: 09725229     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0972-5229.83006     Document Type: Review

References (37)

1. Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, Katsios N, Papastylianou A, Gkisioti S, et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med 2009;169:15-24.
2. Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: Pharmacology and its clinical relevance. Anaesthesia 2004;59:993-1001. (Pubitemid 39307237)
3. Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979;236:F321-32. (Pubitemid 9176167)
4. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003;1:682-9.
5. Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: A prospective randomised study. Circulation 2003;107:2313-9. (Pubitemid 36578501)
6. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87. (Pubitemid 351397087)
7. Robin JK, Oliver JA, Landry DW. Vasopressin deficiency in the syndrome of irreversible shock. J Trauma 2003;54:149-54.
8. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003;31:1752-8. (Pubitemid 36714233)
9. Dünser MW, Hasibeder WR, Wenzel V, Schwarz S, Ulmer H, Knotzer H, et al. Endocrinologic response to vasopressin infusion in advanced vasodilatory shock. Crit Care Med 2004;32:1266-71. (Pubitemid 38738577)
10. Landry DW, Levin HR, Gallant EM, Ashton RC, Jr, Seo S, D'Alessandro D, et al. Vasopressin deficiency contributes to the vasodilatation of septic shock. Circulation 1997;95:1122-5. (Pubitemid 27097820)
11. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign Management Guidelines Comittee: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73. (Pubitemid 38344143)
12. Morales D, Madigan J, Cullinane S, Chen J, Heath M, Oz M, et al. Reversal of vasopressin of intractable hypotension in the late phase of haemorrhagic shock. Circulation 1999;100:226-9. (Pubitemid 29340126)
13. Albright TN, Zimmerman MA, Selzman CH. Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care 2002;11:326-32.
14. Dünser MW, Mayr AJ, Stallinger A, Ulmer H, Ritsch N, Knotzer H, et al. Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med 2002;28:746-51. (Pubitemid 34639488)
15. Kill C, Wranze E, Wulf H. Sucessful treatment of severe anaphylactic shock with vasopressin. Int Arch Allergy Immunol 2004;134:260-1. (Pubitemid 38813041)
16. Tsuda A, Tanaka KA, Huraux C, Szlam F, Sato N, Yamaguchi K, et al. The in vitro reversal of histamine-induced vasodilatation in the human internal mammary artery. Anaesth Analg 2001;93:1453-9. (Pubitemid 33111668)
17. De Kock M, Laterre PF, Andruetto P, Vanderessen L, Dekrom S, Vanderick B, et al. Ornipressin (Por 8): An efficient alternative to counteract hypotension during combined general/epidural anaesthesia. Anesth Analg 2000;90:1301-7. (Pubitemid 30351327)
18. Yeh CC, Wu CT, Lu CH, Yang CP, Wong CS. Early use of small dose vasopressin for unstable haemodynamics in an acute brain injury patient refractory to catecholamine treatment: A case report. Anesth Analg 2003;97:577-9.
19. Bradley PG, Allen EK, Menon DK. Terlipressin for cerebral perfusion pressure support in a patient with septic shock. Anaesthesia 2004;59:619-20. (Pubitemid 38744905)
20. Jochberger S, Wenzel V, Dünser MW Arginine vasopressin as a rescue vasopressor agent in the operating room. Curr Opin Anaesthesiol 2005;18:396-404. (Pubitemid 41073136)
21. Chen JM, Cullinane S, Spanier TB, Artrip JH, John R, Edwards NM, et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999;100:244-6.
22. Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: Clinical and experimental approaches. Circ Shock 1986;18:141-55. (Pubitemid 16181521)
23. Augoustides JG, Abrams M, Berkowitz D, Fraker D. Vasopressin for hemodynamic rescue in catecholamine-resistant vasoplegic shock after resection of massive pheochromocytoma. Anesthesiology 2004;101:1022-4. (Pubitemid 39288055)
24. Veall GR, Peacock JE, Bax ND, Reilly CS. Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. Br J Anaesth1994;72:335-41. (Pubitemid 24089746)
25. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-82. (Pubitemid 34193495)
26. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004;350:105-13. (Pubitemid 38056221)
27. Mukoyama T, Kinoshita K, Nagao K, Tanjoh K. Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation 2009;80:755-61.
28. Ioannou G, Doust J, Rockey DC Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003;1:CD002147.
29. Ozgönenel B, Rajpurkar M, Lusher JM. How do you treat bleeding disorders with desmopressin? Postgrad Med J 2007;83:159-63. (Pubitemid 46465518)
30. Toumba M, Stanhope R. Morbidity and mortality associated with vasopressin analogue treatment. J Pediatr Endocrinol Metab 2006;19:197-201.
31. Kahn JM, Kress JP, Hall JB. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Criti Care Med 2002;30:1899-901. (Pubitemid 34879611)
32. Stiell IG, Hébert PC, Wells GA, Vandemheen KL, Tang AS, Higginson LA, et al. Vasopressin versus epinephrine for inhospital cardiac arrest: A randomised controlled trial. Lancet 2001;358:105-9. (Pubitemid 32709848)
33. Morris DC, Dereczyk BE, Grzybowski M, Martin GB, Rivers EP Wortsman J, et al. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 1997;4:878-83. (Pubitemid 27381660)
34. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996;124:1061-4.
35. Grmec S, Kamenik B & Mally S.Vasopressin in refractory out-of-hospital ventricular fibrillation: Preliminary results. Crit Care 2002;6:P162.
36. Sharshar T, Annane D. Endocrine effects of vasopressin in critically ill patients. Best Pract Res Clin Anaesthesiol 2008;22:265-73. (Pubitemid 351816778)
37. Lin IY, Ma HP, Lin AC, Chong CF, Lin CM, Wang TL. Low plasma vasopressin/norepinephrine ratio predicts septic shock. Am J Emerg Med 2005;23:718-24. (Pubitemid 41354937)